702 filings
Page 2 of 36
DEFA14A
652o6ofl5rfp3ic 8ild
16 Jun 22
Additional proxy soliciting materials
4:15pm
DEFA14A
z4r8oyfl21v 09a6xj54
16 Jun 22
Additional proxy soliciting materials
4:15pm
8-K
s0hbpjaeqqt1gpd7s6x
2 Jun 22
Departure of Directors or Certain Officers
4:13pm
8-K
x7553uk
19 May 22
CytRx Announces Distribution of Series D Preferred Stock to Holders of its Common Stock
5:30pm
8-A12G
sa8k72b
19 May 22
Registration of securities
5:01pm
EFFECT
mxa9w5zp 6docn387v
28 Mar 22
Notice of effectiveness
12:15am
424B3
w4nm v2kyww
25 Mar 22
Prospectus supplement
4:19pm
CORRESP
4m42y6aij675ggrvlej
23 Mar 22
Correspondence with SEC
12:00am
8-K
1cpg3n1pplbt3 6s91sf
21 Mar 22
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
8:00am
8-K
9t9423 76qdf
16 Mar 22
Material Modifications to Rights of Security Holders
6:09am
8-K
lnbyjtt965n4geq0tsnl
10 Mar 22
CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates
4:05pm
DEFA14A
9gi5zixa
17 Feb 22
Additional proxy soliciting materials
4:50pm
8-K
cq99e aosl8o4f8
17 Feb 22
FAQ on Issuance of Shares to Armistice Capital and Special Meeting of Shareholders to Approve Increase in Authorized Shares
4:46pm
DEFA14A
86yasv
26 Jan 22
Additional proxy soliciting materials
6:05am